Ubs Group Ag Bioventus Inc. Transaction History

Ubs Group Ag

$611 Billion
Q3 2025

A detailed history of Ubs Group Ag transactions in Bioventus Inc. stock. As of the latest transaction made, Ubs Group Ag holds 71,960 shares of BVS stock, worth $528,906. This represents 0.0% of its overall portfolio holdings.

Number of Shares

71,960

Previous 87,613 17.87%

Holding current value

$528,906

Previous $579,000 16.93%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$6.14 - $7.64 $96,109 - $119,588	-15,653 Reduced 17.87%	71,960 $481,000
Q2 2025 Aug 14, 2025	BUY	$6.2 - $9.51 $256,934 - $394,103	41,441 Added 89.75%	87,613 $579,000
Q1 2025 May 13, 2025	BUY	$8.76 - $11.05 $67,294 - $84,886	7,682 Added 19.96%	46,172 $422,000
Q4 2024 Feb 14, 2025	BUY	$10.5 - $13.71 $43,197 - $56,402	4,114 Added 11.97%	38,490 $404,000
Q3 2024 Nov 14, 2024	BUY	$5.73 - $11.95 $123,768 - $258,119	21,600 Added 169.07%	34,376 $410,000

Q2 2024 Aug 13, 2024	BUY	$3.96 - $6.93 $45,425 - $79,494	11,471 Added 879.0%	12,776 $73,000
Q1 2024 May 13, 2024	SELL	$4.33 - $5.75 $4,637 - $6,158	-1,071 Reduced 45.08%	1,305 $6,000
Q4 2023 Feb 09, 2024	SELL	$2.89 - $5.34 $5,496 - $10,156	-1,902 Reduced 44.46%	2,376 $12,000
Q3 2023 Nov 09, 2023	BUY	$2.8 - $4.94 $6,913 - $12,196	2,469 Added 136.48%	4,278 $14,000
Q2 2023 Aug 11, 2023	SELL	$0.93 - $3.64 $12,943 - $50,661	-13,918 Reduced 88.5%	1,809 $5,000
Q1 2023 May 12, 2023	BUY	$1.07 - $2.95 $3,191 - $8,799	2,983 Added 23.41%	15,727 $16,000
Q4 2022 Feb 08, 2023	BUY	$1.81 - $8.14 $9,723 - $43,728	5,372 Added 72.87%	12,744 $33,000
Q3 2022 Nov 10, 2022	BUY	$6.54 - $9.08 $22,641 - $31,434	3,462 Added 88.54%	7,372 $51,000
Q2 2022 Aug 10, 2022	SELL	$6.82 - $13.82 $8,170 - $16,556	-1,198 Reduced 23.45%	3,910 $27,000
Q1 2022 May 16, 2022	SELL	$11.65 - $15.28 $98,850 - $129,650	-8,485 Reduced 62.42%	5,108 $72,000
Q4 2021 Feb 14, 2022	BUY	$12.37 - $16.77 $168,145 - $227,954	13,593 New	13,593 $197,000
Q3 2021 Nov 15, 2021	SELL	$13.7 - $17.25 $24,016 - $30,239	-1,753 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$13.75 - $18.8 $34,856 - $47,658	-2,535 Reduced 59.12%	1,753 $31,000
Q1 2021 May 12, 2021	BUY	$11.49 - $19.21 $49,269 - $82,372	4,288 New	4,288 $66,000

Others Institutions Holding BVS

# of Institutions

144

Shares Held

50.1M

Call Options Held

42.5K

Put Options Held

100K

View Full List

About Bioventus Inc.

Ticker BVS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 61,664,200
Market Cap $453M
Description
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...

More about BVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account